News

Respicardia amasses $58.5 mln

Minnesota-based Respicardia, Inc, a medical technology company focused on improving heart health, has raised $58.5 million in financing. ZOLL Medical Corporation was the lead investor.

Year in Review: Firms aim to correct gender imbalance

Bigfoot Biomedical rakes in $37 mln

Silicon Valley-based insulin delivery startup Bigfoot Biomedical has raised $37 million in funding. Janus Henderson Investors and Quadrant Capital Advisors led the round with participation from return backers Cormorant Asset Management, Senvest Capital Inc., Senvest Management LLC, Visionnaire Ventures, JDRF T1D Fund and T1D Exchange.

Ottawa’s $400 mln VC blueprint eyes late-stage ventures, gender disparity

Ottawa has unveiled the details of its $400 million program to shore up venture capital supply in Canada, giving particular focus to backing late-stage tech and righting gender imbalances. The Venture Capital Catalyst Initiative, first announced in March's federal Budget 2017, was launched today by the Liberal government to channel $1.5 billion of new money into Canada’s innovation ecosystem. VCCI will do this by leveraging private commitments to VC funds, primarily through market intermediaries. Every $1 VCCI allocates through Business Development Bank of Canada must be matched by $2.25 from private sources, such as corporations, institutional investors and wealthy individuals. The matching formula, a unique feature of current Canadian public policy in the VC space, is based on one already tested in the market by VCCI’s predecessor.

Walden to raise $250 mln third China venture capital fund

Walden International has set out to raise a $250 million third venture capital fund targeting China, according to a filing with the SEC.

Stitch Health grabs Series A funding

San Francisco-based Stitch Health, a care coordination platform for healthcare teams, has raised an undisclosed amount of Series A funding, according to a blog post. Bill Gurley of Benchmark led the round with participation from Y Combinator.

Hadean Ventures raises $118 million life sciences venture capital fund

Nordic-based Hadean Ventures said it raised a $118 million venture capital fund to invest in life sciences companies, according to a press release.

AEPONYX locks in C$4.3 mln seed

Quebec-based AEPONYX, a provider of micro optical switches, has secured C$4.3 million in seed funding. Fonds Innovexport and Ecofuel Fund led the round. AEPONYX was incubated at Silicon Catalyst.

Aptinyx lands $70 mln Series B

Aptinyx Inc, a developer of treatments for neurologic disorders, has closed $70 million in Series B financing. Bain Capital Life Sciences led the round with participation from other investors that included Adage Capital, Agent Capital, HBM Healthcare Investments, Nan Fung Life Sciences, Partner Fund Management, Rock Springs Capital, New Leaf Venture Partners, Frazier Healthcare Partners, Longitude Capital, Osage University Partners, Adams Street Partners and Beecken Petty O'Keefe & Company.

Year in Review: Gender disparity for women founders seeking cash